|
|
||||||||
1 From the Departments of Ophthalmology, 3 Neurology, and 4 Neurologic Surgery and the 2 Center for Molecular Medicine, Emory University School of Medicine, Atlanta, Georgia.
PURPOSE. To characterize the pathologic features in retina, optic nerve, and extraocular muscle of mitochondrial superoxide dismutase (Sod2)deficient mice, a model of increased mitochondrial production of reactive oxygen species.
METHODS. Morphometric and ultrastructural study of eyes of 43 homozygous sod2tm1Cje-/- mice and wild-type control animals. For retinal morphometric analysis, 32 manganese 5,10,15,20-tetrakis (4-benzoic acid) porphyrin (MnTBAP)treated animals aged either 9 to 10 days or 20 to 21 days were studied. Ultrastructural examination was performed on tissue from the treated animals, and 11 additional untreated mutant and control animals.
RESULTS. In treated Sod2-deficient animals, the photoreceptor layer was thinner centrally at 9 to 10 days than in control animals (mean 8.8 vs. 14.7 µm). By 20 to 21 days, all retinal layers apart from the outer nuclear layer and retinal pigment epithelium (RPE) were thinner centrally in mutant animals (total retinal thickness, 233.2 vs. 272.6 µm; combined nerve fiber layer, ganglion cell layer, and inner plexiform layer, 86.2 vs. 103.4 µm; inner nuclear layer, 51.8 vs. 60.3 µm; photoreceptors, 26.7 vs. 35.6 µm). Optic nerve cross-sectional area was less in 20- to 21-day-old treated Sod2-deficient animals than in control animals. Mitochondrial morphologic abnormalities (swelling, pale matrix, and disorganized cristae) were found predominantly in older mutant animals (16 and 20 to 21 days) RPE and in extraocular muscle of a 16-day-old untreated mutant.
CONCLUSIONS. In sod2tm1Cje-/- mice, there is relative progressive retinal thinning, with particular involvement of the inner retinal layers and an early effect on the photoreceptor layer, as well as mitochondrial morphologic abnormalities, all consistent with mitochondrial disease.
This article has been cited by other articles:
![]() |
K. Hashizume, M. Hirasawa, Y. Imamura, S. Noda, T. Shimizu, K. Shinoda, T. Kurihara, K. Noda, Y. Ozawa, S. Ishida, et al. Retinal Dysfunction and Progressive Retinal Cell Death in SOD1-Deficient Mice Am. J. Pathol., May 1, 2008; 172(5): 1325 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Justilien, J.-J. Pang, K. Renganathan, X. Zhan, J. W. Crabb, S. R. Kim, J. R. Sparrow, W. W. Hauswirth, and A. S. Lewin SOD2 Knockdown Mouse Model of Early AMD Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4407 - 4420. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imamura, S. Noda, K. Hashizume, K. Shinoda, M. Yamaguchi, S. Uchiyama, T. Shimizu, Y. Mizushima, T. Shirasawa, and K. Tsubota Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: A model of age-related macular degeneration PNAS, July 25, 2006; 103(30): 11282 - 11287. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kasahara, L.-R. Lin, Y.-S. Ho, and V. N. Reddy SOD2 Protects against Oxidation-Induced Apoptosis in Mouse Retinal Pigment Epithelium: Implications for Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3426 - 3434. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ding, M. Scortegagna, R. Seaman, D. G. Birch, and J. A. Garcia Retinal Disease in Mice Lacking Hypoxia-Inducible Transcription Factor-2{alpha} Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1010 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kowluru and S. N. Abbas Diabetes-Induced Mitochondrial Dysfunction in the Retina Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5327 - 5334. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qi, A. S. Lewin, W. W. Hauswirth, and J. Guy Optic Neuropathy Induced by Reductions in Mitochondrial Superoxide Dismutase Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1088 - 1096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |